Web Flow - Login to access your portal

PCI Appoints Two New additions to its Commercial Packaging Sales Team

PCI Pharma Services announces the appointment of Nigel Hindes and Laurent Rozier as Business Development Managers. They both join PCI to support the development of the company’s commercial packaging business across Europe.

Both Hindes and Rozier will support a number of key accounts and help drive the continued growth of business in Europe. Their main focus will be the growth of our commercial packaging business, primarily from the Hay-on-Wye facility in the UK. With significant investment in Serialization capabilities, their appointments have come at a critical time as we further our work with clients on strategies to address the European Falsified Medicines Directive (EU FMD).

Hindes will have responsibility for the UK and Ireland, and has previously worked with other leading contract manufacturing organizations (CMO) providing pharmaceutical manufacturing and packaging services. He also has extensive sales experience within the fast-moving consumer goods industry (FMCG) in Europe and brings substantial knowledge and expertise to PCI’s commercial packaging services. This includes primary and secondary packaging, analytical laboratory services, and QP services, as well as working with clients to prepare them for the implementation of Serialization.

Rozier, who will be based in France, will be responsible for supporting the growth of business in Southern Europe. He brings more than ten years’ experience of working within the pharmaceutical packaging industry, providing companies with innovative solutions designed to enhance product shelf-life and quality. He has worked with many of the industry’s major pharmaceutical companies, and his insights and expertise will continue to enable PCI to provide packaging solutions and technologies that truly differentiate products.

Commenting on both appointments, Robbie Stewart, Business Development Director at PCI, stated: “We are delighted to welcome Nigel and Laurent to the commercial packaging team. They both bring a great deal of experience and a proven track record in business development across the pharma sector.
“The commercial packaging business in Europe has seen robust growth in the last few years as we continue to deliver outstanding service to our clients. I am sure that both will be successful in their roles and their knowledge will be invaluable in supporting customers as they look for innovative thinking in bringing new medicines products to market.

Hindes stated: “I am very excited to join PCI at a time when we are seeing such interest in our commercial packaging business, from Serialization services to the growth of biological medicines that we support from our Hay-on-Wye site. I look forward to leveraging my experience and the considerable expertise at PCI to deliver clients the industry’s leading experience.

Rozier added: “I am thrilled to be joining PCI Pharma Services at such an exciting time as the business continues to expand, and I’m particularly excited to be working with companies across Europe to help drive further commercial growth for PCI.

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *

ten + 12 =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...